[HTML][HTML] Niacin in the central nervous system: an update of biological aspects and clinical applications

V Gasperi, M Sibilano, I Savini, MV Catani - International journal of …, 2019 - mdpi.com
Niacin (also known as “vitamin B3” or “vitamin PP”) includes two vitamers (nicotinic acid and
nicotinamide) giving rise to the coenzymatic forms nicotinamide adenine dinucleotide (NAD) …

[HTML][HTML] The role of vitamins in neurodegenerative disease: An update

SN Rai, P Singh, HWM Steinbusch, E Vamanu… - Biomedicines, 2021 - mdpi.com
Acquiring the recommended daily allowance of vitamins is crucial for maintaining
homeostatic balance in humans and other animals. A deficiency in or dysregulation of …

[HTML][HTML] Nicotinamide, a poly [ADP-ribose] polymerase 1 (PARP-1) inhibitor, as an adjunctive therapy for the treatment of Alzheimer's disease

F Salech, DP Ponce, AC Paula-Lima… - Frontiers in Aging …, 2020 - frontiersin.org
Nicotinamide (vitamin B3) is a key component in the cellular production of Nicotinamide
Adenine Dinucleotide (NAD) and has long been associated with neuronal development …

[HTML][HTML] Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities

X Xu, B Sun, C Zhao - Neurobiology of Disease, 2023 - Elsevier
Abstract Poly (ADP-ribose) polymerase-1 (PARP-1) is the most extensively studied member
of the PARP superfamily, with its primary function being the facilitation of DNA damage …

Rutin and selenium co-administration reverse 3-nitropropionic acid-induced neurochemical and molecular impairments in a mouse model of Huntington's disease

MS Abdelfattah, SEA Badr, SA Lotfy, GH Attia… - Neurotoxicity …, 2020 - Springer
Systemic administration of 3-nitropropionic acid (3-NPA) is commonly used to induce
Huntington's disease (HD)-like symptoms in experimental animals. Here, the potential …

[HTML][HTML] Impaired redox signaling in Huntington's disease: therapeutic implications

BD Paul, SH Snyder - Frontiers in molecular neuroscience, 2019 - frontiersin.org
Huntington's disease (HD) is a neurodegenerative disease triggered by expansion of
polyglutamine repeats in the protein huntingtin. Mutant huntingtin (mHtt) aggregates and …

An overview of the pathophysiological mechanisms of 3-nitropropionic acid (3-NPA) as a neurotoxin in a huntington's disease model and its relevance to drug …

S Upadhayay, NG Yedke, V Rahi, S Singh… - Neurochemical …, 2023 - Springer
Animal models are used to better understand the various mechanisms involved in the
pathogenesis of diseases and explore potential pathways that will aid in discovering …

[HTML][HTML] Inhibition of Brain GTP cyclohydrolase I attenuates 3-nitropropionic acid-induced striatal toxicity: involvement of Mas receptor/PI3k/Akt/CREB/BDNF axis

AM Mustafa, MA Rabie, HF Zaki… - Frontiers in …, 2021 - frontiersin.org
GTP cyclohydrolase I (GTPCH I) is the rate-limiting enzyme for tetrahydrobiopterin (BH4)
biosynthesis; the latter is an essential factor for iNOS activation that contributes neuronal …

Nicotinamide Phosphoribosyltransferase Positive Allosteric Modulators Attenuate Neuronal Oxidative Stress

J Gordon-Blake, K Ratia, V Weidig… - ACS Medicinal …, 2024 - ACS Publications
Evidence supports boosting nicotinamide adenine dinucleotide (NAD+) to counteract
oxidative stress in aging and neurodegenerative disease. One approach is to enhance the …

[HTML][HTML] Reactive species in Huntington disease: are they really the radicals you want to catch?

J Bono-Yagüe, AP Gómez-Escribano, JM Millán… - Antioxidants, 2020 - mdpi.com
Huntington disease (HD) is a neurodegenerative condition and one of the so-called rare or
minority diseases, due to its low prevalence (affecting 1–10 of every 100,000 people in …